The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease
Julius Wilder,1,2 Keyur Patel1,21Division of Gastroenterology, Duke University School of Medicine, 2Duke Clinical Research Institute, Durham, NC, USAAbstract: An important aspect of managing chronic liver disease is assessing for evidence of fibrosis. Historically, this has been accomplished using...
Guardado en:
Autores principales: | Wilder J, Patel K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/beb8e85e185041509442cefbb2ee8b35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders
por: Dalby RN, et al.
Publicado: (2011) -
Recent advances in noninvasive glucose monitoring
por: So CF, et al.
Publicado: (2012) -
Evaluation of the angled Episcissors-60® episiotomy scissors in spontaneous vaginal deliveries
por: Patel RP, et al.
Publicado: (2014) -
Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
por: VanDevanter DR, et al.
Publicado: (2011) -
Assessment of noninvasive, percutaneous hemoglobin measurement in pregnant and early postpartum women
por: Yoshida A, et al.
Publicado: (2014)